全文获取类型
收费全文 | 42323篇 |
免费 | 2550篇 |
国内免费 | 1399篇 |
专业分类
耳鼻咽喉 | 146篇 |
儿科学 | 1200篇 |
妇产科学 | 730篇 |
基础医学 | 2362篇 |
口腔科学 | 89篇 |
临床医学 | 4755篇 |
内科学 | 12440篇 |
皮肤病学 | 71篇 |
神经病学 | 1239篇 |
特种医学 | 1303篇 |
外国民族医学 | 2篇 |
外科学 | 4030篇 |
综合类 | 7990篇 |
现状与发展 | 5篇 |
预防医学 | 1980篇 |
眼科学 | 787篇 |
药学 | 5006篇 |
29篇 | |
中国医学 | 1701篇 |
肿瘤学 | 407篇 |
出版年
2024年 | 42篇 |
2023年 | 534篇 |
2022年 | 765篇 |
2021年 | 1456篇 |
2020年 | 1476篇 |
2019年 | 1234篇 |
2018年 | 1319篇 |
2017年 | 1260篇 |
2016年 | 1362篇 |
2015年 | 1348篇 |
2014年 | 2748篇 |
2013年 | 3665篇 |
2012年 | 2246篇 |
2011年 | 2314篇 |
2010年 | 2039篇 |
2009年 | 1939篇 |
2008年 | 1887篇 |
2007年 | 2032篇 |
2006年 | 1865篇 |
2005年 | 1621篇 |
2004年 | 1413篇 |
2003年 | 1329篇 |
2002年 | 1105篇 |
2001年 | 1066篇 |
2000年 | 903篇 |
1999年 | 781篇 |
1998年 | 675篇 |
1997年 | 729篇 |
1996年 | 584篇 |
1995年 | 616篇 |
1994年 | 542篇 |
1993年 | 361篇 |
1992年 | 370篇 |
1991年 | 296篇 |
1990年 | 265篇 |
1989年 | 217篇 |
1988年 | 236篇 |
1987年 | 201篇 |
1986年 | 176篇 |
1985年 | 230篇 |
1984年 | 211篇 |
1983年 | 100篇 |
1982年 | 134篇 |
1981年 | 131篇 |
1980年 | 141篇 |
1979年 | 77篇 |
1978年 | 57篇 |
1977年 | 49篇 |
1976年 | 46篇 |
1974年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
21.
22.
《Actas urologicas espa?olas》2020,44(5):281-288
Male infertility accounts for 50% of the causes of infertile couples, being more than 30% of unknown etiology. In these cases, empiric treatment can be an option prior to the application of assisted reproduction techniques. Empiric treatment can be categorized as hormonal, such as gonadotropins, antiestrogens and aromatase inhibitors, and antioxidant, with vitamins, trace elements and carnitine, among others. Although scientifically acceptable evidence is limited due to the absence of large randomized and controlled clinical trials, recent systematic reviews and meta-analyses show that treatment with gonadotropins, antiestrogens and antioxidants increases pregnancy and live birth rates and improves seminal parameters. Empiric medical treatment for idiopathic infertility can be considered in specific cases in order to improve semen quality and spontaneous fertility. 相似文献
23.
目的:回顾性分析芪地固肾方治疗特发性膜性肾病(IMN)的临床疗效与安全性。方法:选取2014年1月至2017年6月陕西中医药大学附属医院肾病科门诊及住院IMN患者141例,根据用药方案分为西药组(西药标准疗法)、中西药结合组(芪地固肾方+西药标准疗法)和中药组(芪地固肾方)3组各47例,观察3组患者治疗后临床疗效、复发率及不良反应等。结果:治疗6个月后,中西药结合组和西药组总有效率72.34%、68.09%高于中药组,治疗12个月时3组有效率比较差异无统计学意义,治疗18个月后中药组和中西药结合组总有效率75.76%、78.72%高于西药组。中药组和中西药结合组在治疗12个月和18个月后较西药组在提高中医证候疗效、减少中医证候积分上更具优势。中药组和中西药结合组复发率更低,3组均未出现严重不良反应。结论:芪地固肾方能提高IMN缓解率,在提高中医证候疗效、降低复发率上更具优势,远期疗效可观,值得进一步推广应用。 相似文献
24.
《Cor et vasa》2015,57(3):e157-e162
IntroductionObstructive sleep apnea (OSA) is often connected with arterial hypertension and it could also be a cause of secondary hypertension. Treatment of arterial hypertension and optimal blood pressure level are important for prevention of cardiovascular complications. It is not well known how to treat patients with OSA and arterial hypertension. Also many patients with OSA suffer from metabolic syndrome which worsen their prognosis.AimThe aim of our study was to assess arterial hypertension compensation in patients with metabolic syndrome and moderate to severe OSA and to analyze used pharmacotherapy.Materials and methods85 hypertensive patients (75 men) with metabolic syndrome, average age 53.6 ± 9.3 years, were evaluated using overnight sleep study with diagnosis of OSA, average apnea–hypopnea index (AHI) 56.3 ± 23. Patients underwent 24 h ambulatory blood pressure monitoring (ABPM) and their current pharmacotherapy data were obtained. Appropriate combinations of antihypertensive drugs (patients with metabolic syndrome) were derived from ESH/ESC 2013 guidelines.ResultsArterial hypertension was well compensated in only 11.8% of the patients. 24.7% patients were treated according to current guidelines. Fisher's exact test with analysis of adjusted residues has found higher rate of blood pressure subcompensation in patients treated with triple+ combination of drugs (p = 0.035, 51.4% vs 10%).ConclusionOnly a small number of patients had optimal blood pressure level and were treated according to current ESH/ESC guidelines. We have to constantly appeal to all physicians to perform ABPM in patients with OSA. 相似文献
25.
26.
Tian-Yuan Xiong Fang-Yang Huang Qi Liu Yong Peng Yuan-Ning Xu Jia-Fu Wei 《Annals of medicine》2020,52(7):361-366
Abstract
Background
Comorbidities are commonly seen in patients with coronavirus disease 2019 (COVID-19), but the clinical implication is not yet well-delineated. We aim to characterize the prevalence and clinical implications of comorbidities in patients with COVID-19. 相似文献27.
28.
29.
30.
Wilbert S Aronow 《Expert opinion on pharmacotherapy》2016,17(2):205-215
Introduction: It is important to know how to treat hypertension in patients with coronary artery disease (CAD). The reason for the review was to update this treatment and to discuss the 2015 American Heart Association/American College of Cardiology/American Society of Hypertension 2015 guidelines of treatment of hypertension in patients with CAD.Areas covered: Studies between 1968 and 2015 were reviewed on treatment of hypertension in patients with CAD using a Medline search, and studies between 1977 and 2015 were reported. Hypertension should be treated with beta blockers and ACE inhibitors or angiotensin receptor blockers (ARBs). Long-acting nitrates are effective antianginal and anti-ischemic drugs. Calcium-channel blockers (CCBs) may be added if angina persists despite beta blockers and long-acting nitrates. The 2015 guidelines recommend that the blood pressure should be < 140/90 mm Hg in patients aged ≤ 80 years and the systolic blood pressure < 150 mm Hg if they are ≥ 80 years.Expert opinion: Hypertension in patients with CAD should be treated with beta blockers and ACE inhibitors or ARBs. Long-acting nitrates are effective antianginal and anti-ischemic drugs. CCBs may be added if angina persists despite beta blockers and long-acting nitrates. The blood pressure should be < 140/90 mm Hg in patients aged < 80 years and the systolic blood pressure < 150 mm Hg if they are ≥ 80 years. 相似文献